International Clinical Trial: An Invest-Initiated Trial (IIT) to Evaluate the Safety and Efficacy of Coriolus Versicolor Intracellular Glycopeptide Oral Solution Combined with Chemotherapy Plus PD-1/PD-L1 Inhibitors in Participants with Moderately Advanced and Advanced Non-Small Cell Lung Cancer

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123250) titled 'An Invest-Initiated Trial (IIT) to Evaluate the Safety and Efficacy of Coriolus Versicolor Intracellular Glycopeptide Oral Solution Combined with Chemotherapy Plus PD-1/PD-L1 Inhibitors in Participants with Moderately Advanced and Advanced Non-Small Cell Lung Cancer' on April 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China Hospital of Sichuan University

Condition: non-small cell lung cancer (NSCLC)

Intervention: Control Group:Platinum-based doublet chemotherapy and PD-1/PD-L1 monoclonal antibody treatment. At the same time, it is also possible to provide preventive or ...